Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
HY-N0155 |
Nobiletin |
|
99.52% |
Unkown |
HY-113071A |
Mevalonic acid lithium salt |
|
99.80% |
Unkown |
HY-40171 |
NH2-C2-NH-Boc |
|
99.97% |
Unkown |
HY-W021401 |
Amino-PEG3-C2-Azido |
|
99.67% |
Unkown |
HY-N0376 |
Liquiritin |
|
99.68% |
Unkown |
HY-140213 |
Azido-PEG2-C2-amine |
|
99.85% |
Unkown |
HY-130109 |
N3-PEG4-C2-NHS ester |
|
98.94% |
Unkown |
HY-101180 |
C2 Ceramide |
|
99.85% |
Unkown |
HY-42776 |
NH2-PEG3-C2-NH-Boc |
|
99.34% |
Unkown |
HY-W008474 |
Boc-NH-PEG2-C2-NH2 |
|
99.01% |
Unkown |
HY-100594 |
EUK-134 |
Inhibitor |
98.08% |
Unkown |
HY-128834 |
N3-PEG4-C2-NH2 |
|
≥98.0% |
Unkown |
HY-122502 |
Pyrazofurin |
Inhibitor |
≥98.0% |
Unkown |
HY-150795 |
SY-LB-35 |
|
≥98.0% |
Unkown |
HY-126528 |
N3-PEG3-C2-NHS ester |
|
99.94% |
Unkown |
HY-130653 |
Azido-PEG4-C2-acid |
|
≥98.0% |
Unkown |
HY-126526 |
N3-PEG2-C2-NHS ester |
|
≥98.0% |
Unkown |
HY-140452 |
Azido-PEG2-C2-acid |
|
≥97.0% |
Unkown |
HY-130485 |
Bromo-PEG2-C2-azide |
|
98.10% |
Unkown |
HY-42149 |
NH2-PEG2-C2-Boc |
|
≥98.0% |
Unkown |
HY-W015088 |
Amino-PEG3-C2-Amine |
|
99.32% |
Unkown |
HY-137320 |
diABZI-C2-NH2 |
Agonist |
96.09% |
Unkown |
HY-N0602 |
Ginsenoside Rg2 |
Inhibitor |
98.11% |
Unkown |
HY-135804 |
NH2-PEG3-C2-Boc |
|
≥97.0% |
Unkown |
HY-112821 |
IBS008738 |
Activator |
98.22% |
Unkown |
HY-130549 |
Acid-PEG3-C2-Boc |
|
≥97.0% |
Unkown |
HY-107452 |
SLF-amido-C2-COOH |
|
99.82% |
Unkown |
HY-125843 |
Pomalidomide-PEG1-C2-N3 |
|
99.91% |
Unkown |
HY-W092043 |
TLR4-IN-C34-C2-COOH |
Inhibitor |
≥97.0% |
Unkown |
HY-W022240 |
NH2-PEG5-C2-NH-Boc |
|
≥95.0% |
Unkown |
HY-147007 |
β-catenin-IN-3 |
Inhibitor |
98.03% |
Unkown |
HY-150644 |
S07-2010 |
Inhibitor |
99.79% |
Unkown |
HY-156406 |
PITCOIN4 |
Inhibitor |
99.97% |
Unkown |
HY-42151 |
Mal-amido-PEG2-C2-acid |
|
99.58% |
Unkown |
HY-130436 |
Acid-C2-PEG4-C2-NHS ester |
|
≥98.0% |
Unkown |
HY-140009 |
Azido-PEG1-C2-acid |
|
≥98.0% |
Unkown |
HY-D0187S |
L-Glutathione reduced-13C2,15N |
Inhibitor |
≥99.0% |
Unkown |
HY-126502 |
Mal-C2-NHS ester |
|
99.30% |
Unkown |
HY-W017970 |
Boc-C2-NH2 |
|
99.63% |
Unkown |
HY-124569 |
NAB-14 |
Antagonist |
/ |
Unkown |
HY-126520 |
N3-C2-NHS ester |
|
≥98.0% |
Unkown |
HY-140480 |
Acid-PEG2-C2-Boc |
|
≥98.0% |
Unkown |
HY-141364 |
Bromo-PEG1-C2-Boc |
|
98.58% |
Unkown |
HY-163084 |
HJ445A |
Inhibitor |
98.31% |
Unkown |
HY-108307 |
Micronomicin sulfate |
Inhibitor |
≥98.0% |
Unkown |
HY-112820 |
Chlorantraniliprole |
Activator |
98.06% |
Unkown |
HY-147025 |
(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine |
|
99.06% |
Unkown |
HY-148896 |
(S,R,S)-AHPC-C2-PEG3-BCN |
|
≥98.0% |
Unkown |
HY-W040165 |
Amino-PEG3-C2-acid |
|
99.94% |
Unkown |
HY-101159 |
Mal-amido-PEG8-C2-acid |
|
99.04% |
Unkown |
HY-112452 |
SU11652 |
|
99.06% |
Unkown |
HY-128846A |
Pomalidomide-C2-NH2 hydrochloride |
|
99.46% |
Unkown |
HY-148346A |
STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA |
Agonist |
98.30% |
Unkown |
HY-22335 |
Amino-PEG4-C2-amine |
|
≥98.0% |
Unkown |
HY-B0351S2 |
Taurine-13C2,15N |
Inducer |
98.60% |
Unkown |
HY-W040168 |
Amino-PEG2-C2-acid |
|
≥98.0% |
Unkown |
HY-131880 |
Thalidomide-O-C2-acid |
Inducer |
95.04% |
Unkown |
HY-137531 |
Pomalidomide-PEG1-C2-COOH |
|
99.76% |
Unkown |
HY-119678 |
Fortunellin |
Activator |
96.51% |
Unkown |
HY-124648 |
SMN-C2 |
|
98.85% |
Unkown |
HY-130315 |
Br-PEG4-C2-Boc |
|
≥98.0% |
Unkown |
HY-130483 |
Br-PEG3-C2-Boc |
|
≥97.0% |
Unkown |
HY-140127 |
Azide-C2-SS-C2-biotin |
|
98.79% |
Unkown |
HY-W021448S1 |
Glycocyamine-15N,13C2 |
|
≥97.0% |
Unkown |
HY-112706 |
PF-06747711 |
Antagonist |
99.86% |
Unkown |
HY-129703B |
Thalidomide-PEG2-C2-NH2 hydrochloride |
Inducer |
99.89% |
Unkown |
HY-112599B |
Pomalidomide-PEG4-C2-NH2 hydrochloride |
|
97.01% |
Unkown |
HY-N0322S5 |
Cholesterol-13C2 |
Agonist |
99.76% |
Unkown |
HY-N0543S |
Allantoin-13C2,15N4 |
|
99.90% |
Unkown |
HY-N1517 |
Ganoderic acid C2 |
|
99.30% |
Unkown |
HY-W010098S1 |
Terephthalic acid-13C2 |
|
98.58% |
Unkown |
HY-W039168 |
Bromo-PEG3-C2-acid |
|
≥97.0% |
Unkown |
HY-W580022 |
Pomalidomide-5'-PEG8-C2-COOH |
|
98.21% |
Unkown |
HY-128716A |
Pomalidomide-PEG3-C2-NH2 TFA |
|
99.0% |
Unkown |
HY-130683 |
Lenalidomide-propargyl-C2-NH2 hydrochloride |
|
98.04% |
Unkown |
HY-128832 |
Nutlin-C1-amido-PEG4-C2-N3 |
|
99.19% |
Unkown |
HY-115384 |
Amino-PEG5-C2-acid |
|
≥97.0% |
Unkown |
HY-135868 |
Mito-apocynin (C2) |
Inhibitor |
98.38% |
Unkown |
HY-139848 |
WS-898 |
Inhibitor |
98.14% |
Unkown |
HY-140543 |
N-DBCO-N-bis(PEG2-C2-acid) |
|
96.65% |
Unkown |
HY-140585 |
N-DBCO-N-bis(PEG2-C2-NHS ester) |
|
≥96.0% |
Unkown |
HY-141386 |
Bromoacetamido-PEG2-C2-NHS ester |
|
≥95.0% |
Unkown |
HY-23167 |
Acid-PEG4-C2-Boc |
|
/ |
Unkown |
HY-B0228S10 |
(R)-3-Hydroxybutanoic acid-13C2 sodium |
|
≥98.0% |
Unkown |
HY-N7627 |
Regaloside C |
|
≥99.0% |
Unkown |
HY-P5881 |
PKCα (C2-4) inhibitor peptide |
Inhibitor |
99.81% |
Unkown |
HY-Y0262S1 |
Oxalic acid-13C2 |
|
99.45% |
Unkown |
HY-Y0966S3 |
Glycine-13C2 |
|
99.10% |
Unkown |
HY-Y0966S6 |
Glycine-13C2,15N |
|
≥99.0% |
Unkown |
HY-N0091S3 |
Hypoxanthine-13C2,15N |
|
≥91.0% |
Unkown |
HY-13836 |
ELQ-300 |
Inhibitor |
≥98.0% |
Unkown |
HY-122710A |
Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride |
Inducer |
≥95.0% |
Unkown |
HY-136163 |
(S,R,S)-AHPC-C2-NH2 dihydrochloride |
|
98.63% |
Unkown |
HY-130108 |
N3-PEG4-C2-Pfp ester |
|
≥97.0% |
Unkown |
HY-130414 |
Mal-amido-PEG4-acid |
|
99.39% |
Unkown |
HY-133597 |
4-Chlorocatechol |
|
99.37% |
Unkown |
HY-134512 |
Aminooxy-PEG3-C2-thiol |
|
≥95.0% |
Unkown |
HY-140819 |
Bromo-PEG1-C2-azide |
|
99.45% |
Unkown |
HY-B0351S1 |
Taurine-13C2 |
Inducer |
99.0% |
Unkown |
HY-129703A |
Thalidomide-PEG2-C2-NH2 TFA |
Inducer |
99.39% |
Unkown |
HY-107440A |
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride |
Inducer |
98.29% |
Unkown |
HY-112608 |
CHMFL-PI3KD-317 |
Inhibitor |
98.04% |
Unkown |
HY-122694A |
Thalidomide-O-amido-PEG-C2-NH2 hydrochloride |
Inducer |
98.10% |
Unkown |
HY-130521 |
Pomalidomide-amido-PEG3-C2-NH2 |
|
99.55% |
Unkown |
HY-100246 |
CI-1044 |
Inhibitor |
98.02% |
Unkown |
HY-115450 |
ONO-0300302 |
Antagonist |
99.43% |
Unkown |
HY-126512 |
Propargyl-C2-NHS ester |
|
≥95.0% |
Unkown |
HY-126688 |
Mal-C2-Gly3-EDA-PNU-159682 |
|
93.43% |
Unkown |
HY-126881 |
Fmoc-PEG2-C2-NHS ester |
|
98.89% |
Unkown |
HY-130095 |
NHPI-PEG2-C2-NHS ester |
|
98.23% |
Unkown |
HY-130101 |
Ald-Ph-amido-PEG4-C2-NHS ester |
|
98.75% |
Unkown |
HY-130396 |
DBCO-PEG4-C2-acid |
|
99.22% |
Unkown |
HY-130520 |
Bromoacetamido-PEG4-C2-Boc |
|
≥97.0% |
Unkown |
HY-130531 |
NH-bis(C2-PEG2-NH-Boc) |
|
≥98.0% |
Unkown |
HY-131295 |
PD0325901-O-C2-dioxolane |
Inhibitor |
98.76% |
Unkown |
HY-131866 |
(S,R,S)-CO-C2-acid |
|
≥98.0% |
Unkown |
HY-134682 |
Fmoc-NH-PEG5-C2-NH2 |
|
98.06% |
Unkown |
HY-136162 |
Thalidomide-4-O-C2-NH2 hydrochloride |
Inducer |
99.37% |
Unkown |
HY-13966S2 |
2-Deoxy-D-glucose-13C |
|
≥98.0% |
Unkown |
HY-141362 |
Bromo-PEG2-C2-acid |
|
≥97.0% |
Unkown |
HY-145245 |
TLR4-IN-C34-C2-amide-C6-OH |
Inhibitor |
99.62% |
Unkown |
HY-148080 |
Indole-C2-amide-C2-NH2 |
|
99.42% |
Unkown |
HY-162809 |
XMU-MP-9 |
|
98.16% |
Unkown |
HY-B0389S15 |
D-Glucose-13C2-4 |
|
≥98.0% |
Unkown |
HY-N6980 |
Licorice glycoside C2 |
|
99.07% |
Unkown |
HY-133358 |
Cbz-NH-PEG12-C2-acid |
|
95.66% |
Unkown |
HY-W017387S1 |
Sodium α-ketoisocaproic acid-13C2 |
|
98.1% |
Unkown |
HY-W025074 |
BML-278 |
Activator |
98.49% |
Unkown |
HY-W128417S |
4-(Dimethylamino)phenacyl bromide-13C2,d6 |
|
98.14% |
Unkown |
HY-107440 |
Thalidomide-O-amido-PEG3-C2-NH2 |
Inducer |
/ |
Unkown |
HY-112600A |
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA |
Inducer |
99.28% |
Unkown |
HY-112617A |
Thalidomide-O-amido-PEG2-C2-NH2 TFA |
Inducer |
99.72% |
Unkown |
HY-128591 |
DIPQUO |
Activator |
98.70% |
Unkown |
HY-130682 |
Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride |
|
/ |
Unkown |
HY-130853 |
Thalidomide-NH-PEG2-C2-NH-Boc |
Inducer |
98.37% |
Unkown |
HY-112599 |
Pomalidomide-PEG4-C2-NH2 |
|
95.11% |
Unkown |
HY-103154 |
SB228357 |
Antagonist |
99.43% |
Unkown |
HY-103611 |
Thalidomide-O-amido-PEG3-C2-NH2 TFA |
Inducer |
99.55% |
Unkown |
HY-108440 |
Shz-1 |
|
99.88% |
Unkown |
HY-113071 |
Mevalonic acid |
|
≥99.0% |
Unkown |
HY-120773 |
Fmoc-PEG3-C2-NHS ester |
|
≥95.0% |
Unkown |
HY-121982 |
Cyclo(L-Phe-L-Val) |
Inhibitor |
99.88% |
Unkown |
HY-126381 |
Boc-N-PEG5-C2-NHS ester |
|
96.91% |
Unkown |
HY-126507 |
Mal-amido-PEG1-C2-NHS ester |
|
99.69% |
Unkown |
HY-126509 |
Mal-amido-PEG10-C2-NHS ester |
|
95.23% |
Unkown |
HY-128716 |
Pomalidomide-PEG3-C2-NH2 |
|
/ |
Unkown |
HY-128716B |
Pomalidomide-PEG3-C2-NH2 hydrochloride |
|
/ |
Unkown |
HY-128846 |
Pomalidomide-C2-NH2 |
|
/ |
Unkown |
HY-128848 |
Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH |
|
95.02% |
Unkown |
HY-130091 |
NHPI-PEG4-C2-NHS ester |
|
98.88% |
Unkown |
HY-130097 |
Ald-Ph-amido-PEG4-C2-acid |
|
99.09% |
Unkown |
HY-130104 |
Ald-Ph-amido-PEG2-C2-NHS ester |
|
98.51% |
Unkown |
HY-130470 |
Chloroacetamido-PEG4-C2-Boc |
|
/ |
Unkown |
HY-133070 |
Tos-PEG5-C2-Boc |
|
/ |
Unkown |
HY-135085 |
Thiol-C2-PEG2-OH |
|
≥97.0% |
Unkown |
HY-136395 |
Cartap |
Inducer |
/ |
Unkown |
HY-13677S1 |
6-Mercaptopurine-13C2,15N |
|
≥96.0% |
Unkown |
HY-138446 |
Amino-PEG4-C2-SH hydrochloride |
|
≥95.0% |
Unkown |
HY-138451 |
Amino-PEG7-C2-SH hydrochloride |
|
≥98.0% |
Unkown |
HY-140779 |
Azido-PEG6-C2-Boc |
|
99.77% |
Unkown |
HY-141941S |
Triazole Lactic Acid-13C2, 15N3 |
|
/ |
Unkown |
HY-148136 |
sEH inhibitor-7 |
Inhibitor |
99.71% |
Unkown |
HY-148346 |
STING agonist-20-Ala-amide-PEG2-C2-NH2 |
Agonist |
/ |
Unkown |
HY-148484 |
Pomalidomide-5'-PEG5-C2-COOH |
|
98.80% |
Unkown |
HY-160897 |
Methoxy-PEG-C3-amide-C2-Mal |
|
99.69% |
Unkown |
HY-164367 |
Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT |
|
/ |
Unkown |
HY-16973S |
Fluralaner-13C2,15N,d3 |
Inhibitor |
98.35% |
Unkown |
HY-66005S4 |
Acetaminophen-13C2,15N |
|
/ |
Unkown |
HY-A0132S10 |
N-Acetyl-D-glucosamine-13C2,15N |
|
/ |
Unkown |
HY-B0166S3 |
L-Ascorbic acid-13C-2 |
|
≥95.0% |
Unkown |
HY-B0318S |
Metronidazole-13C2,15N2 |
|
99.30% |
Unkown |
HY-I0960S |
Uracil-13C2,15N2 |
|
≥97.0% |
Unkown |
HY-N0229S15 |
L-Alanine-13C2,15N |
|
≥99.0% |
Unkown |
HY-N0229S9 |
L-Alanine-13C2 |
|
≥98.0% |
Unkown |
HY-N0437S3 |
Progesterone-13C2 |
Agonist |
99.7% |
Unkown |
HY-N0455AS5 |
L-Arginine-1,2-13C2 hydrochloride |
Activator |
98.9% |
Unkown |
HY-N0666S6 |
L-Aspartic acid-1,4-13C2 |
|
≥99.0% |
Unkown |
HY-N0830S10 |
Palmitic acid-13C2 |
Activator |
99.54% |
Unkown |
HY-P2741 |
Maltose phosphorylase |
|
/ |
Unkown |
HY-W013636S3 |
2-Ketoglutaric acid-13C |
|
≥97.0% |
Unkown |
HY-W040795 |
N2-Acetylguanine |
|
99.69% |
Unkown |
HY-W127841 |
Citric acid-2,4-13C2 |
|
98.00% |
Unkown |
HY-Y0674S |
Dicyandiamide-13C2,15N2 |
|
99.90% |
Unkown |
HY-103708 |
Nezukone |
|
98.81% |
Unkown |
HY-159193S |
DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA |
|
97.61% |
Unkown |
HY-47373 |
Folate-PEG3-C2-acid |
|
97.56% |
Unkown |
HY-112600 |
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 |
Inducer |
/ |
Unkown |
HY-112617 |
Thalidomide-O-amido-PEG2-C2-NH2 |
Inducer |
/ |
Unkown |
HY-112617B |
Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride |
Inducer |
/ |
Unkown |
HY-122694 |
Thalidomide-O-amido-PEG-C2-NH2 |
Inducer |
/ |
Unkown |
HY-128353 |
ROR agonist-1 |
Antagonist |
/ |
Unkown |
HY-129703 |
Thalidomide-PEG2-C2-NH2 |
Inducer |
/ |
Unkown |
HY-131308 |
Thalidomide-NH-C2-PEG3-OH |
Inducer |
/ |
Unkown |
HY-136160 |
Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride |
Inducer |
/ |
Unkown |
HY-141662 |
2',3'-cGAMP-C2-PPA |
Agonist |
/ |
Unkown |
HY-122710 |
Thalidomide-O-amido-PEG4-C2-NH2 |
|
/ |
Unkown |
HY-125883 |
Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc |
|
/ |
Unkown |
HY-100441S1 |
Treprostinil-13C2,d1 |
Inhibitor |
/ |
Unkown |
HY-101047S1 |
D-erythro-Sphingosine-13C2,d2 |
|
/ |
Unkown |
HY-101108S1 |
Tazarotenic acid-13C2,d2 |
|
/ |
Unkown |
HY-103155 |
SB-221284 |
Antagonist |
/ |
Unkown |
HY-108379 |
Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid |
|
/ |
Unkown |
HY-108826 |
Iduronate sulfatase |
|
/ |
Unkown |
HY-109506S9 |
DPPC-13C2 |
|
/ |
Unkown |
HY-110189S |
Pregnenolone monosulfate sodium-13C2,d2 |
|
/ |
Unkown |
HY-111095S3A |
D-(-)-Lactic acid-13C-2 sodium |
|
/ |
Unkown |
HY-111555 |
AmPEG6C2-Aur0131 |
Inhibitor |
/ |
Unkown |
HY-113071C |
(S)-Mevalonic acid |
|
/ |
Unkown |
HY-113263S1 |
17α-Hydroxypregnenolone-13C2,d2 |
|
/ |
Unkown |
HY-113295S |
Salicyluric acid-13C2,15N |
|
/ |
Unkown |
HY-113365S2 |
Cholestenone-13C2 |
|
/ |
Unkown |
HY-115945 |
Complex III-IN-1 |
Inhibitor |
/ |
Unkown |
HY-116877 |
C2 Ceramide (d14:1/2:0) |
|
/ |
Unkown |
HY-117356A |
MRS2693 ammonium |
|
/ |
Unkown |
HY-118574 |
UBP141 |
Antagonist |
/ |
Unkown |
HY-121507 |
Hydroxy-PEG2-C2-sulfonic acid |
|
/ |
Unkown |
HY-123439 |
FTY720-C2 |
|
/ |
Unkown |
HY-125172 |
PolyQ aggregation inhibitor C2-8 |
|
/ |
Unkown |
HY-125887 |
Boc-NH-PEG2-C2-amido-C4-acid |
|
/ |
Unkown |
HY-126026 |
NF-κB-IN-17 |
Inhibitor |
/ |
Unkown |
HY-126313 |
BnOH-NH-bis-(C2-S)-propane-O-isoprene ester |
|
/ |
Unkown |
HY-126508 |
Mal-amido-PEG5-C2-NHS ester |
|
/ |
Unkown |
HY-12650S |
Mirogabalin-13C2,d1 (Mixture of Diastereomers) |
|
/ |
Unkown |
HY-126510 |
MC-PEG2-C2-NHS ester |
|
/ |
Unkown |
HY-126514 |
Propargyl-O-C1-amido-PEG2-C2-NHS ester |
|
/ |
Unkown |
HY-126515 |
Propargyl-O-C1-amido-PEG4-C2-NHS ester |
|
/ |
Unkown |
HY-126527 |
N3-PEG2-C2-PFP ester |
|
/ |
Unkown |
HY-126529 |
N3-PEG3-C2-PFP ester |
|
/ |
Unkown |
HY-126673 |
Mal-C2-Gly3-EDA |
|
/ |
Unkown |
HY-126677 |
Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA |
|
/ |
Unkown |
HY-126949 |
Aminooxy-PEG3-azide |
|
/ |
Unkown |
HY-128741S2 |
D-Allose-13C-2 |
|
/ |
Unkown |
HY-128753S3 |
D-Lyxose-13C-2 |
|
/ |
Unkown |
HY-128793S |
trans-Stilbene-13C2 |
|
/ |
Unkown |
HY-129772 |
Phthalimide-PEG3-C2-OTs |
|
/ |
Unkown |
HY-130090 |
NHPI-PEG4-C2-Pfp ester |
|
/ |
Unkown |
HY-130092 |
NHPI-PEG3-C2-Pfp ester |
|
/ |
Unkown |
HY-130093 |
NHPI-PEG3-C2-NHS ester |
|
/ |
Unkown |
HY-130094 |
NHPI-PEG2-C2-Pfp ester |
|
/ |
Unkown |
HY-130096 |
Ald-Ph-amido-C2-nitrate |
|
/ |
Unkown |
HY-130102 |
Ald-Ph-amido-PEG3-C2-Pfp ester |
|
/ |
Unkown |
HY-130103 |
Ald-Ph-amido-PEG2-C2-Pfp ester |
|
/ |
Unkown |
HY-130105 |
Ald-Ph-amido-PEG1-C2-Pfp ester |
|
/ |
Unkown |
HY-130106 |
Ald-Ph-amido-PEG1-C2-NHS ester |
|
/ |
Unkown |
HY-130154 |
Ald-Ph-amido-PEG2-C2-acid |
|
/ |
Unkown |
HY-130164 |
Bromo-PEG3-C2-phosphonic acid |
|
/ |
Unkown |
HY-130174 |
Ald-Ph-amido-PEG3-C2-NH2 |
|
/ |
Unkown |
HY-130192 |
Cbz-NH-PEG8-C2-acid |
|
/ |
Unkown |
HY-130202 |
Ald-Ph-amido-PEG2-C2-Boc |
|
≥97.0% |
Unkown |
HY-130443 |
Cbz-NH-PEG6-C2-acid |
|
/ |
Unkown |
HY-130467 |
DNP-NH-PEG2-C2-acid |
|
/ |
Unkown |
HY-130488 |
Hydroxy-PEG2-C2-PFP ester |
|
/ |
Unkown |
HY-130489 |
Bromo-PEG5-C2-acid |
|
/ |
Unkown |
HY-130491 |
DNP-NH-PEG4-C2-Boc |
|
/ |
Unkown |
HY-130654 |
(S,R,S)-AHPC-C2-PEG4-N3 |
|
/ |
Unkown |
HY-130667 |
Ald-Ph-amido-C2-PEG3-azide |
|
98.92% |
Unkown |
HY-130669 |
Ald-Ph-amido-C2-PEG3-NH-Boc |
|
/ |
Unkown |
HY-130690 |
Propargyl-PEG1-SS-PEG1-C2-Boc |
|
≥98.0% |
Unkown |
HY-130712 |
NH2-C2-amido-C2-Boc |
|
/ |
Unkown |
HY-130713 |
Thalidomide-C2-amido-C2-COOH |
Inducer |
/ |
Unkown |
HY-130758 |
Ald-PEG1-C2-Boc |
|
/ |
Unkown |
HY-130931 |
Propargyl-NH-PEG3-C2-NHS ester |
|
/ |
Unkown |
HY-131992 |
N-Acetylpsychosine |
|
/ |
Unkown |
HY-132973 |
MC-Val-Cit-PAB-NH-C2-NH-Boc |
|
≥95.0% |
Unkown |
HY-133069 |
Tos-PEG2-C2-Boc |
|
/ |
Unkown |
HY-133071 |
Tos-PEG6-C2-Boc |
|
/ |
Unkown |
HY-133410 |
Mal-C2-cyclohexylcarboxyl-hydrazide TFA |
|
/ |
Unkown |
HY-133410A |
Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride |
|
98.23% |
Unkown |
HY-133509 |
DBCO-C2-SulfoNHS ester |
|
/ |
Unkown |
HY-133546 |
Ald-Ph-amido-PEG11-C2-NH2 |
|
/ |
Unkown |
HY-133583 |
Propargyl-O-C1-amido-PEG3-C2-NHS ester |
|
/ |
Unkown |
HY-13407S |
Gossypol-13C2 |
|
/ |
Unkown |
HY-13417S |
AICAR-13C2,15N |
|
/ |
Unkown |
HY-13458S1 |
Droxidopa-13C2,15N hydrochloride |
|
/ |
Unkown |
HY-135931 |
m-PEG11-C2-NHS Ester |
|
/ |
Unkown |
HY-135959 |
DBCO-NH-PEG7-C2-NHS ester |
|
/ |
Unkown |
HY-136162A |
Thalidomide-4-O-C2-NH2 |
Inducer |
/ |
Unkown |
HY-136163A |
(S,R,S)-AHPC-C2-NH2 |
|
/ |
Unkown |
HY-13623CS |
(1R,3S,4R)-ent-Entecavir-13C2,15N |
|
/ |
Unkown |
HY-13623S1 |
Entecavir-13C2,15N |
|
/ |
Unkown |
HY-138083 |
Parvodicin C2 |
Inhibitor |
/ |
Unkown |
HY-138316 |
THP-PEG10-C2-Boc |
|
/ |
Unkown |
HY-138349 |
THP-PEG6-C2-Boc |
|
/ |
Unkown |
HY-138358 |
Azido-PEG23-C2-azide |
|
/ |
Unkown |
HY-138362 |
Br-PEG6-C2-acid |
|
/ |
Unkown |
HY-138370 |
Boc-NH-PEG4-C2-Boc |
|
/ |
Unkown |
HY-138375 |
Mal-PEG5-C2-NH2 hydrochloride |
|
/ |
Unkown |
HY-138380 |
Mal-PEG4-C2-NH2 TFA |
|
/ |
Unkown |
HY-138381 |
Br-PEG6-C2-NHBoc |
|
/ |
Unkown |
HY-138384 |
Br-PEG9-C2-NHBoc |
|
/ |
Unkown |
HY-138390 |
NH2-PEG10-C2-dimethylamino |
|
/ |
Unkown |
HY-138397 |
Boc-NH-PEG15-C2-acid |
|
/ |
Unkown |
HY-138399 |
Boc-NH-PEG22-C2-NH2 |
|
/ |
Unkown |
HY-138406 |
Boc-NH-PEG8-C2-Br |
|
/ |
Unkown |
HY-138410 |
Boc-NH-PEG11-C2-acid |
|
/ |
Unkown |
HY-138425 |
Amino-PEG12-C2-azide |
|
/ |
Unkown |
HY-138432 |
Boc-NH-PEG26-C2-NH2 |
|
/ |
Unkown |
HY-138464 |
Br-Boc-C2-azido |
|
/ |
Unkown |
HY-138474 |
Boc-PEG1-PPG2-C2-azido |
|
/ |
Unkown |
HY-138485 |
Boc-PEG1-PPG2-C2-NH2 |
|
/ |
Unkown |
HY-138535 |
Azide-C2-Azide |
|
/ |
Unkown |
HY-138849 |
Thalidomide-NH-amido-C2-NH2 |
Inducer |
/ |
Unkown |
HY-138849A |
Thalidomide-NH-amido-C2-NH2 hydrochloride |
Inducer |
/ |
Unkown |
HY-138854 |
Thalidomide-NH-amido-PEG1-C2-NH2 |
Inducer |
/ |
Unkown |
HY-138854A |
Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride |
Inducer |
/ |
Unkown |
HY-138855 |
Thalidomide-NH-amido-PEG2-C2-NH2 |
Inducer |
/ |
Unkown |
HY-138855A |
Thalidomide-NH-amido-PEG2-C2-NH2 hydrochloride |
Inducer |
/ |
Unkown |
HY-138856 |
Thalidomide-NH-amido-PEG3-C2-NH2 |
Inducer |
/ |
Unkown |
HY-138856A |
Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride |
|
/ |
Unkown |
HY-138857 |
Thalidomide-NH-amido-PEG4-C2-NH2 |
|
/ |
Unkown |
HY-138857A |
Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride |
|
/ |
Unkown |
HY-138965A |
Pomalidomide-5-C2-NH2 hydrochloride |
|
/ |
Unkown |
HY-139084 |
XL388-C2-NH2 |
|
/ |
Unkown |
HY-139085A |
XL388-C2-amide-PEG9-NH2 hydrochloride |
|
≥95.0% |
Unkown |
HY-139085B |
XL388-C2-amide-PEG9-NH2 TFA |
|
95.97% |
Unkown |
HY-140001 |
Amino-PEG3-C2-sulfonic acid |
|
/ |
Unkown |
HY-140011 |
Acid-C2-PEG3-NHS ester |
|
/ |
Unkown |
HY-140067 |
endo-BCN-PEG2-C2-NHS ester |
|
/ |
Unkown |
HY-140085 |
N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) |
|
/ |
Unkown |
HY-140101 |
Azido-C2-SS-PEG2-C2-acid |
|
/ |
Unkown |
HY-140164 |
Azido-PEG2-C2-sulfonic acid |
|
/ |
Unkown |
HY-140221 |
Azido-PEG1-C2-methylamine |
|
/ |
Unkown |
HY-140287 |
DBCO-C2-PEG4-amine |
|
/ |
Unkown |
HY-140294 |
DBCO-C2-PEG4-NH-Boc |
|
/ |
Unkown |
HY-140349 |
AZD-CO-C2-Ph-amido-Ph-azide |
|
/ |
Unkown |
HY-140406 |
Aminooxy-PEG3-C2-NH-Boc |
|
/ |
Unkown |
HY-140487 |
Cbz-NH-PEG2-C2-acid |
|
/ |
Unkown |
HY-140489 |
Cbz-NH-PEG5-C2-acid |
|
/ |
Unkown |
HY-140514 |
NH-bis(PEG2-C2-acid) |
|
/ |
Unkown |
HY-140550 |
NH-bis(C2-PEG1-azide) |
|
/ |
Unkown |
HY-140554 |
N-Boc-N-bis(C2-PEG1-azide) |
|
/ |
Unkown |
HY-140595 |
m-PEG3-S-PEG1-C2-Boc |
|
/ |
Unkown |
HY-140633 |
Ald-C2-PEG4-azide |
|
/ |
Unkown |
HY-140750 |
Benzyloxy carbonyl-PEG3-C2-Boc |
|
/ |
Unkown |
HY-140776 |
Azido-PEG2-C2-Boc |
|
/ |
Unkown |
HY-140834 |
Boc-N-Amido-PEG2-C2-azide |
|
/ |
Unkown |
HY-141116 |
Boc-N-PEG1-C2-NHS ester |
|
/ |
Unkown |
HY-141122 |
Boc-PEG4-C2-NHS ester |
|
/ |
Unkown |
HY-141245 |
Hydroxy-PEG4-C2-nitrile |
|
/ |
Unkown |
HY-141323 |
C2-Bis-phosphoramidic acid diethyl ester |
|
/ |
Unkown |
HY-141388 |
Bromoacetamido-PEG3-C2-Boc |
|
/ |
Unkown |
HY-141663 |
2',3'-cGAMP-C2-SH |
|
/ |
Unkown |
HY-141798 |
OICR-9429-N-C2-NH2 |
|
/ |
Unkown |
HY-141878 |
di-Ellipticine-RIBOTAC |
Modulator |
/ |
Unkown |
HY-143784S |
C14 Benzalkonium-1 acid-13C2,d11 chloride |
|
/ |
Unkown |
HY-143943S |
Felodipine 3,5-dimethyl ester-13C2,d6 |
|
/ |
Unkown |
HY-144128 |
hGGPPS-IN-1 |
|
/ |
Unkown |
HY-144129 |
hGGPPS-IN-2 |
|
/ |
Unkown |
HY-144130 |
hGGPPS-IN-3 |
|
/ |
Unkown |
HY-144150S |
Pelubiprofen impurity 2-13C2,d6 |
|
/ |
Unkown |
HY-144153S |
S-(1,2-Dichlorovinyl)glutathione-13C2,15N |
|
/ |
Unkown |
HY-144427S |
Vitamin E-13C2,d6 |
|
/ |
Unkown |
HY-145247 |
Biotin-PEG7-C2-S-Vidarabine |
Inhibitor |
/ |
Unkown |
HY-145248 |
Biotin-PEG7-C2-NH-Vidarabine-S-CH3 |
Inhibitor |
/ |
Unkown |
HY-145253 |
Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH |
Inhibitor |
/ |
Unkown |
HY-145255 |
Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH |
Inhibitor |
/ |
Unkown |
HY-14608S10 |
L-Glutamic acid-13C2 |
|
/ |
Unkown |
HY-146194 |
NHEJ inhibitor-1 |
Activator |
/ |
Unkown |
HY-146196 |
Anticandidal agent-1 |
Inhibitor |
/ |
Unkown |
HY-146573 |
AKR1C3-IN-6 |
Inhibitor |
/ |
Unkown |
HY-146994S2 |
L-Idose-13C-2 |
|
/ |
Unkown |
HY-147716 |
CDK8-IN-6 |
Inhibitor |
/ |
Unkown |
HY-147717 |
CDK8-IN-7 |
Inhibitor |
/ |
Unkown |
HY-147835 |
Antibacterial agent 109 |
Inhibitor |
/ |
Unkown |
HY-148171 |
L-2'-Fd4C |
Inhibitor |
/ |
Unkown |
HY-148472A |
C2-Amide-C4-NH2 |
|
/ |
Unkown |
HY-148662 |
Pomalidomide-PEG5-C2-NH2 hydrochloride |
|
/ |
Unkown |
HY-149255 |
PTP1B/AKR1B1-IN-2 |
Inhibitor |
/ |
Unkown |
HY-150525S |
Acetyl-1,2 Coenzyme A-13c2 Lithium |
|
/ |
Unkown |
HY-150623 |
SARS-CoV-2 nsp13-IN-2 |
Inhibitor |
/ |
Unkown |
HY-150631S |
Glutathione-glycine-13C2,15N trifluoroacetate |
|
/ |
Unkown |
HY-150915S |
Uracil 4,5-13c2 |
|
/ |
Unkown |
HY-152297 |
(1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol |
|
/ |
Unkown |
HY-152305 |
(1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol |
|
/ |
Unkown |
HY-152463 |
4′-C-2-Propen-1-yluridine |
|
/ |
Unkown |
HY-153042 |
Thalidomide-NH-C2-azaspiro[3.5]nonane hydrochloride |
|
/ |
Unkown |
HY-153371 |
50-C2-C9-4tail |
|
/ |
Unkown |
HY-153538 |
AP-C2 |
Inhibitor |
/ |
Unkown |
HY-15388S1 |
Tazarotene-13C2,d2 |
|
/ |
Unkown |
HY-155705 |
BMP agonist 1 |
|
/ |
Unkown |
HY-156304 |
Coumarin-C2-TCO |
|
/ |
Unkown |
HY-156305 |
Coumarin-C2-exo-BCN |
|
/ |
Unkown |
HY-156882 |
Biotin-PEG3-amide-C2-CO-Halofuginone |
|
/ |
Unkown |
HY-157386S |
8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2 |
|
/ |
Unkown |
HY-157588 |
(S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH |
Inducer |
/ |
Unkown |
HY-157749 |
Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 |
Inducer |
/ |
Unkown |
HY-157758 |
(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 |
Inducer |
/ |
Unkown |
HY-157759 |
(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH |
Inducer |
/ |
Unkown |
HY-157760 |
(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH |
Inducer |
/ |
Unkown |
HY-160449 |
p53 Activator 10 |
Activator |
/ |
Unkown |
HY-160514 |
LXQ46 |
Inhibitor |
/ |
Unkown |
HY-161183 |
(S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc |
Inducer |
/ |
Unkown |
HY-161184 |
Deoxy-thalidomide-piperidine-C-piperazine-C2-OH |
Inducer |
/ |
Unkown |
HY-161186 |
Thalidomide-piperidine-C-azetidine-C2-O-C-boc |
Inducer |
/ |
Unkown |
HY-161188 |
Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH |
Inducer |
/ |
Unkown |
HY-161189 |
Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc |
Inducer |
/ |
Unkown |
HY-161190 |
Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH |
Inducer |
/ |
Unkown |
HY-161191 |
Thalidomide-azetidine-piperazine-C2-O-C2-OH |
Inducer |
/ |
Unkown |
HY-161197 |
Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH |
Inducer |
/ |
Unkown |
HY-161199 |
Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH |
Inducer |
/ |
Unkown |
HY-161200 |
Thalidomide-piperazine-C-azetidine-C2-OH |
Inducer |
/ |
Unkown |
HY-161202 |
Thalidomide-piperidine-O-piperidine-C2-OH |
Inducer |
/ |
Unkown |
HY-161203 |
Thalidomide-azetidine-piperazine-C2-O-C-boc |
Inducer |
/ |
Unkown |
HY-161250 |
Pomalidomide-NH-PEG6-amide-C2-CPI-1612 |
|
/ |
Unkown |
HY-161393 |
RB-CO-PEG5-C2-CO-VH032 |
|
/ |
Unkown |
HY-161394 |
SPRT |
|
/ |
Unkown |
HY-161767 |
JWJ-01-306 |
|
/ |
Unkown |
HY-161839 |
AKR1C2/3-IN-1 |
Inhibitor |
/ |
Unkown |
HY-161910 |
SH-E4A-66 |
Inhibitor |
/ |
Unkown |
HY-162046 |
Anticancer agent 178 |
Inducer |
/ |
Unkown |
HY-162081 |
BTK-IN-32 |
Inhibitor |
/ |
Unkown |
HY-16271S |
Kevetrin hydrochloride-13C2,15N3 |
p53 Activator |
/ |
Unkown |
HY-163078 |
C2-Gal-Dox |
|
/ |
Unkown |
HY-163224 |
(S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc |
|
/ |
Unkown |
HY-163228 |
PROTAC PTK6 ligand-O-C2-O-piperidine-Boc |
|
/ |
Unkown |
HY-163788 |
C5-CONH-C2-N-CH3 |
|
/ |
Unkown |
HY-163903 |
OH-C2-PEG3-NHCO-C3-COOH |
|
/ |
Unkown |
HY-163904 |
(S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH |
|
/ |
Unkown |
HY-163930 |
(S,R,S)-AHPC-CO-cyclohexane-C2 |
|
/ |
Unkown |
HY-163986 |
Pomalidomide-C2-NHCO-C6 |
|
/ |
Unkown |
HY-164210 |
DBCO-PEG2-C2-acid |
|
/ |
Unkown |
HY-164212 |
DBCO-PEG1-OH |
|
/ |
Unkown |
HY-164785 |
TCO-PEG5-C2-Mal |
|
≥95.0% |
Unkown |
HY-168016 |
PROTAC YAP degrader-1 |
|
/ |
Unkown |
HY-168019 |
(R,S,R)-AHPC-PEG2-C2-boc |
|
/ |
Unkown |
HY-169082 |
JQ-1 (carboxylic acid)-NH-C2-NH-COOH |
|
/ |
Unkown |
HY-169141 |
BIIB021-NH-C2-piperidine-CO-Me |
|
/ |
Unkown |
HY-169150 |
JQ-1 carboxylic acid-PEG3-C2-NH2 |
|
/ |
Unkown |
HY-169236 |
COOH-C-PEG2-NHCO-C2-COOH |
|
/ |
Unkown |
HY-169237 |
Pomalidomide-C2-CONH-PEG2-C-COOH |
|
/ |
Unkown |
HY-17416AS1 |
Guanfacine-15N3,13C2 |
Agonist |
/ |
Unkown |
HY-17530S |
Aldicarb sulfone-13C2,d3 |
|
/ |
Unkown |
HY-34628S2 |
Tri-O-acetyl-D-glucal-13C-2 |
|
/ |
Unkown |
HY-40171S |
NH2-C2-NH-Boc-d4 |
|
/ |
Unkown |
HY-48394A |
Bis-S-C2-N(N-Me)-C2-OH dihydrochloride |
|
/ |
Unkown |
HY-77956S2 |
Thyminose-13C-2 |
|
/ |
Unkown |
HY-79369S1 |
Succinic anhydride-13C2 |
|
/ |
Unkown |
HY-90009AS |
Tadalafil-13C2,d3 |
|
/ |
Unkown |
HY-A0084S1 |
Procainamide-13C2 hydrochloride |
|
/ |
Unkown |
HY-B0101S1 |
Fluconazole-13C2,15N |
Inhibitor |
/ |
Unkown |
HY-B0141S5 |
Estradiol-13C2 |
Agonist |
/ |
Unkown |
HY-B0149S3 |
Tranexamic acid-13C2,15N |
|
/ |
Unkown |
HY-B0151S1 |
Pregnenolone-13C2,d2 |
|
/ |
Unkown |
HY-B0216S2 |
Ethynyl Estradiol-13C2 |
Agonist |
/ |
Unkown |
HY-B0220S3 |
Erythromycin-13C2 |
Inhibitor |
/ |
Unkown |
HY-B0234S3 |
Estrone-13C2 |
Agonist |
/ |
Unkown |
HY-B0283S1 |
Acipimox-13C2,15N2 |
|
/ |
Unkown |
HY-B0389S12 |
D-Glucose-13C-2 |
|
/ |
Unkown |
HY-B0389S14 |
D-Glucose-13C2 |
|
/ |
Unkown |
HY-B0389S22 |
D-Glucose-13C2,d2 |
|
/ |
Unkown |
HY-B0400S3 |
D-Sorbitol-13C-2 |
|
/ |
Unkown |
HY-B0495S3 |
Lamotrigine-13C2,15N |
|
/ |
Unkown |
HY-B0495S6 |
Lamotrigine-13C2,15N2,d3 |
|
/ |
Unkown |
HY-B0508S1 |
Ornidazole-13C2,15N2 |
Inhibitor |
/ |
Unkown |
HY-B0523S |
Anagrelide-13C2,15N,d2 |
|
/ |
Unkown |
HY-B0579S3 |
Cyclosporin A-13C2,d4 |
Inhibitor |
/ |
Unkown |
HY-B0712S1 |
Ceftriaxone-13C2,d3 triethylammonium salt |
Inhibitor |
/ |
Unkown |
HY-B0782S1 |
Acetazolamide-13C2,d3 |
|
/ |
Unkown |
HY-B0863S3 |
Glyphosate-13C2,15N |
Inducer |
/ |
Unkown |
HY-B1118S1 |
Secnidazole-13C2, 15N2 |
Inhibitor |
/ |
Unkown |
HY-B1337S5 |
Choline-13C2 chloride |
|
/ |
Unkown |
HY-B1449S3 |
Uridine-13C-2 |
|
/ |
Unkown |
HY-B1640S |
Ethacrynic acid-13C2,d5 |
|
/ |
Unkown |
HY-B1659S4 |
Glycerol-13C2 |
|
/ |
Unkown |
HY-B1842S |
Fluroxypyr-13C2 |
|
/ |
Unkown |
HY-B1912S1 |
Amidosulfuron-13C2,d6 |
|
/ |
Unkown |
HY-D1546 |
Biotin-C2-maleimide |
|
/ |
Unkown |
HY-D1551 |
10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide |
|
/ |
Unkown |
HY-I0400S2 |
N-Acetylneuraminic acid-13C-2 |
|
/ |
Unkown |
HY-I0626S |
Cytosine-2,4-13C2-1,3-15N2 |
|
/ |
Unkown |
HY-I0736S |
Isonicotinic acid-d4 |
|
/ |
Unkown |
HY-N0059S2 |
D-arabinose-13C-2 |
|
/ |
Unkown |
HY-N0210S1 |
D-Galactose-13C-2 |
|
/ |
Unkown |
HY-N0379S7 |
D-Mannose-13C-2 |
|
/ |
Unkown |
HY-N0390S10 |
L-Glutamine-1,2-13C2 |
|
/ |
Unkown |
HY-N0394S4 |
L-Cystine-3,3'-13C2 |
|
/ |
Unkown |
HY-N0420S3 |
Butanedioic acid-13C2 |
|
≥99.0% |
Unkown |
HY-N0420S4 |
Succinic acid-13C2 |
|
/ |
Unkown |
HY-N0473S6 |
L-Tyrosine-3,5-13C2 |
|
99.43% |
Unkown |
HY-N0545S |
Taurocholic acid-13C2,15N sodium |
Agonist |
/ |
Unkown |
HY-N0602R |
Ginsenoside Rg2 (Standard) |
Inhibitor |
/ |
Unkown |
HY-N0666S7 |
L-Aspartic acid-1,4-13C2,15N |
|
/ |
Unkown |
HY-N10579 |
Chrexanthomycin C |
Modulator |
/ |
Unkown |
HY-N10595 |
Ladanetin-6-O-β-(6′′-O-acetyl)glucoside |
|
/ |
Unkown |
HY-N10642 |
Pedaliin 6''-acetate |
|
/ |
Unkown |
HY-N10869 |
Pseudolaric acid C2-O-β-D-glucoside |
|
/ |
Unkown |
HY-N1150S4 |
Thymidine-13C-2 |
|
/ |
Unkown |
HY-N12447 |
C-2′-Decoumaroylaloeresin G |
|
/ |
Unkown |
HY-N1420AS2 |
Rhamnose-13C-2 monohydrate |
|
/ |
Unkown |
HY-N1480S2 |
(-)-Fucose-13C-2 |
|
/ |
Unkown |
HY-N3205 |
Neochamaejasmin B |
|
/ |
Unkown |
HY-N3231 |
Murraol |
Inhibitor |
/ |
Unkown |
HY-N3671 |
Cycloshizukaol A |
|
/ |
Unkown |
HY-N3686S2 |
D-Arabitol-13C-2 |
|
/ |
Unkown |
HY-N3697 |
Demethoxydeacetoxypseudolaric acid B |
|
99.94% |
Unkown |
HY-N6625S |
Chlorothalonil-13C2 |
Inhibitor |
/ |
Unkown |
HY-N6910 |
Pseudolaric Acid C2 |
|
99.17% |
Unkown |
HY-N7092S3 |
D-Fructose-13C2 |
|
≥98.0% |
Unkown |
HY-N7398S |
2-Pentylfuran-13C2 |
|
/ |
Unkown |
HY-P10655 |
Caloxin 1C2 |
Inhibitor |
/ |
Unkown |
HY-R00539 |
hsa-miR-30c-2-3p mimic |
|
/ |
Unkown |
HY-R00539A |
hsa-miR-30c-2-3p agomir |
|
/ |
Unkown |
HY-RI00539 |
hsa-miR-30c-2-3p inhibitor |
|
/ |
Unkown |
HY-RI00539A |
hsa-miR-30c-2-3p antagomir |
|
/ |
Unkown |
HY-RS00535 |
AKR1C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01199 |
ATP2C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01227 |
ATP6V1C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01738 |
C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01740 |
C2CD3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01741 |
C2CD5 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01742 |
C2orf69 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS05907 |
GTF3C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS05968 |
H3C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS05975 |
H4C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS09537 |
NR2C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS09538 |
NR2C2AP Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS09547 |
NR3C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS09548 |
Nr3c2 Mouse Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS09549 |
Nr3c2 Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS09609 |
NT5C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10511 |
PIK3C2A Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10512 |
Pik3c2a Mouse Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10513 |
Pik3c2a Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10514 |
PIK3C2B Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10515 |
Pik3c2b Mouse Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10516 |
Pik3c2b Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10517 |
PIK3C2G Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10518 |
Pik3c2g Mouse Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10519 |
Pik3c2g Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS14017 |
SULT1C2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-W006057AS |
Sodium 3-methyl-2-oxobutanoate-13C2,d1 |
|
/ |
Unkown |
HY-W006057AS17 |
Sodium 3-Methyl-2-oxobutanoic acid-13C2 |
|
/ |
Unkown |
HY-W006057AS3 |
Sodium 3-methyl-2-oxobutanoate-13C2,d4 |
|
/ |
Unkown |
HY-W008807S |
Phosphoenolpyruvic acid potassium-13C2 |
|
/ |
Unkown |
HY-W010042S2 |
L-Glucose-13C-2 |
|
/ |
Unkown |
HY-W010452S2 |
3-Hydroxybutyric acid-13C2 sodium |
|
/ |
Unkown |
HY-W012684S |
Ethane-1,2-diamine dihydrochloride-13C2 |
|
/ |
Unkown |
HY-W012864S2 |
(2S,3R)-2,3,4-Trihydroxybutanal-13C-2 |
|
99.4% |
Unkown |
HY-W013061S5 |
Propane-1,2,3-triyl tripalmitate-13C2 |
|
/ |
Unkown |
HY-W013495S |
Porphobilinogen-13C2 |
|
/ |
Unkown |
HY-W013636S4 |
2-Ketoglutaric acid-13C2 |
Inhibitor |
/ |
Unkown |
HY-W015410S |
Disodium succinate-13C2 |
|
/ |
Unkown |
HY-W015883AS |
Fumaric acid2,3-13C2 disodium |
|
/ |
Unkown |
HY-W015883S2 |
Fumaric acid-13C2,d2 |
|
/ |
Unkown |
HY-W015913S4 |
2-Oxopropanoate-13c2 sodium |
|
/ |
Unkown |
HY-W017018S1 |
L-Ornithine-1,2-13C2 hydrochloride |
|
/ |
Unkown |
HY-W017072S |
1-Dodecene-1,2-13C2 |
|
/ |
Unkown |
HY-W017522S6 |
Adipic acid-13C2 |
|
/ |
Unkown |
HY-W018772S16 |
D-Ribose-1,2-13C2 |
|
/ |
Unkown |
HY-W018772S3 |
D-Ribose-13C-2 |
|
/ |
Unkown |
HY-W019796 |
Cbz-NH-PEG4-C2-acid |
|
/ |
Unkown |
HY-W035903S |
Ethanolamine-13C2 hydrochloride |
|
/ |
Unkown |
HY-W040028 |
Cartap hydrochloride |
Inducer |
/ |
Unkown |
HY-W040240S2 |
(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 |
|
/ |
Unkown |
HY-W042357S3 |
Ac-rC Phosphoramidite-13C2,d1 |
|
/ |
Unkown |
HY-W048482S |
rU Phosphoramidite-13C2,d1 |
|
/ |
Unkown |
HY-W096111A |
Trt-PEG4-C2-acid hydrate |
|
/ |
Unkown |
HY-W096132 |
Dimethylamino-PEG2-C2-NH2 |
|
/ |
Unkown |
HY-W099580S |
Hexadecane-1,2-13C2 |
|
/ |
Unkown |
HY-W100312S |
o-Toluidine-13C6 hydrochloride |
|
/ |
Unkown |
HY-W338294S1 |
2'-Deoxycytidine-13C-2 monohydrate |
|
/ |
Unkown |
HY-W584529 |
VH032-C2-NH-Boc |
|
/ |
Unkown |
HY-W584532 |
VH032-O-C2-NH-Boc |
|
/ |
Unkown |
HY-W588192S |
1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4 |
|
/ |
Unkown |
HY-W590667 |
C2 Ceramide-1-phosphate |
|
/ |
Unkown |
HY-W766769 |
Cyproterone Acetate-13C2,d3 |
Antagonist |
/ |
Unkown |
HY-W778203 |
Glycolic acid-13C2 |
|
/ |
Unkown |
HY-W877850 |
Mal-C5-N-bis(PEG2-C2-acid) |
|
/ |
Unkown |
HY-Y0219S |
1,2,4-Triazole-13C2,15N3 |
|
/ |
Unkown |
HY-Y0262BS |
Oxalic Acid-13C2 disodium |
|
/ |
Unkown |
HY-Y0338S1 |
Ethylene glycol-13C2 |
|
/ |
Unkown |
HY-Y0383S2 |
Dimethyl terephthalate-13C2-1 |
|
/ |
Unkown |
HY-Y0418S2 |
Dulcite-13C-2 |
|
/ |
Unkown |
HY-Y0677S |
Carbethoxymethyldiethyl phosphonate-C13 |
|
/ |
Unkown |
HY-Y0781S3 |
Pyruvic acid-13C-2 sodium |
|
/ |
Unkown |
HY-Y0966S11 |
Glycine-13C2,15N,d2 |
|
/ |
Unkown |
HY-Y0989S2 |
Acetophenone-1,2-13C2 |
|
/ |
Unkown |
HY-Y1088S |
Hydrocinnamic acid-2,3-13C2 |
|
/ |
Unkown |
HY-Y1250S5 |
Fmoc-Gly-OH-13C2 |
|
/ |
Unkown |
HY-Y1250S6 |
Fmoc-Gly-OH-13C2,15N |
Inhibitor |
/ |
Unkown |
HY-100043S |
2-Ethyl-3,5-dimethylpyrazine-13C2 |
|
/ |
Unkown |
HY-114293S |
Acetyl coenzyme A-13C2 lithium |
Inhibitor |
/ |
Unkown |
HY-116700 |
Hinnuliquinone |
Inhibitor |
/ |
Unkown |
HY-118560S |
Tricyclodecenyl acetate-13C2 |
|
/ |
Unkown |
HY-119799 |
UK-500001 |
Inhibitor |
/ |
Unkown |
HY-121656 |
AKR1C2/3-IN-2 |
|
/ |
Unkown |
HY-125026 |
MyomiRs-IN-1 |
|
/ |
Unkown |
HY-125571 |
A 74704 |
Inhibitor |
/ |
Unkown |
HY-126830 |
Antifolate C2 |
|
/ |
Unkown |
HY-129252 |
Prothracarcin |
Inhibitor |
/ |
Unkown |
HY-130155 |
AMPK activator C2 |
Activator |
/ |
Unkown |
HY-132212 |
LH1307 |
Inhibitor |
/ |
Unkown |
HY-132223 |
LH1306 |
Inhibitor |
/ |
Unkown |
HY-132644S1 |
3-Demethyl Thiocolchicine--13C2,d6 |
|
/ |
Unkown |
HY-135928 |
Biotin-C2-S-S-pyridine |
|
/ |
Unkown |
HY-140157 |
N-Me-N-bis(PEG4-C2-Boc) |
|
/ |
Unkown |
HY-14164S1 |
Zileuton-13C2,15N |
Inhibitor |
/ |
Unkown |
HY-144348S |
N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N |
|
/ |
Unkown |
HY-149559 |
Thalidomide-5-O-C2-NH2 hydrochloride |
|
98.01% |
Unkown |
HY-150006 |
Pomalidomide-C2-acid |
|
/ |
Unkown |
HY-15121S1 |
L-Theanine-13C2,15N2 |
|
/ |
Unkown |
HY-156326S |
(3E,5E)-Octadien-2-one-13C2 |
|
/ |
Unkown |
HY-156326S1 |
(3E,5Z)-Octadien-2-one-13C2 |
|
/ |
Unkown |
HY-158343 |
Thalidomide-NH-PEG2-C2-CH2 |
|
/ |
Unkown |
HY-160069 |
Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH |
|
/ |
Unkown |
HY-160235 |
Pomalidomide-C2-amide-C5-azide |
|
/ |
Unkown |
HY-161773 |
HL389-NHC2-PEG3-C2NH |
|
/ |
Unkown |
HY-164043 |
(S,R,S)-AHPC(Me)-amido-C2-acid |
|
/ |
Unkown |
HY-164391 |
Pomalidomide-C2-amide-C4-Br |
|
/ |
Unkown |
HY-165064 |
C2 L-Erythro ceramide (d18:1/2:0) |
|
/ |
Unkown |
HY-165072 |
C2 3'-Sulfo galactosylceramide (d18:1/2:0) |
|
/ |
Unkown |
HY-166226 |
C2 Sphingomyelin (d18:1/2:0) |
|
/ |
Unkown |
HY-167710 |
CRCD2 |
|
/ |
Unkown |
HY-76204S1 |
Glycine ethyl ester-13C2 hydrochloride |
|
/ |
Unkown |
HY-B0084S3 |
Dienogest-13C2,15N |
Agonist |
/ |
Unkown |
HY-B0124S1 |
Zonisamide-13C2,15N |
|
/ |
Unkown |
HY-B1290S3 |
2-Phenylethanol-13C2 |
Inhibitor |
/ |
Unkown |
HY-N0091S4 |
Hypoxanthine-13C2,15N-1 |
|
/ |
Unkown |
HY-N12156 |
Ajugasterone C 2-acetate |
|
/ |
Unkown |
HY-N12297 |
Ciwujianoside C2 |
|
/ |
Unkown |
HY-N7125S |
Cinnamyl acetate-13C2 |
|
/ |
Unkown |
HY-N7521 |
Procyanidin C2 |
|
/ |
Unkown |
HY-N9484S |
Menthofuran-13C2 |
|
/ |
Unkown |
HY-W001942S2 |
DL-2-Methylbutyric acid-13C2 |
|
/ |
Unkown |
HY-W010392S1 |
Ethyl 2-methylbutanoate-13C2 |
|
/ |
Unkown |
HY-W010489S1 |
2-Phenylacetaldehyde-13C2 |
|
/ |
Unkown |
HY-W012980S4 |
Isovaleric acid-13C2 |
|
/ |
Unkown |
HY-W012998S1 |
2,3-Pentanedione-13C2 |
|
/ |
Unkown |
HY-W015307S |
4-Ethyloctanoic acid-13C2 |
|
/ |
Unkown |
HY-W015604S |
2,3-Diethyl-5-methylpyrazine-13C2 |
|
/ |
Unkown |
HY-W017049S |
Trifluoroacetic acid-13C2 sodium |
|
/ |
Unkown |
HY-W020678S |
2-Methylbutanal-13C2 |
|
/ |
Unkown |
HY-W102356S1 |
Phenethyl acetate-13C2 |
|
/ |
Unkown |
HY-W127515S |
trans-2,cis-6-Nonadienal-13C2 |
|
/ |
Unkown |
HY-W343292S |
2-Methylbutyl acetate-13C2 |
|
/ |
Unkown |
HY-W590664 |
C2 Dihydroceramide |
|
/ |
Unkown |
HY-W654105 |
C18-Ceramide-13C2,d2 |
|
/ |
Unkown |
HY-W654190 |
Fipronil sulfone-13C2,15N2 |
|
/ |
Unkown |
HY-W654241 |
Isopentenyl pyrophosphate-13C2 |
|
/ |
Unkown |
HY-W749251 |
5-Aminolevulinic acid-13C2,15N hydrochloride |
|
/ |
Unkown |
HY-W777583 |
2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 |
|
/ |
Unkown |
HY-W778064 |
L-threo-Droxidopa-13C2,15N |
|
/ |
Unkown |
HY-W778154 |
O,O-Dimethyl dithiophosphate-13C2 ammonium |
Inhibitor |
/ |
Unkown |
HY-W779002 |
alpha-D-glucose-13C2-1 |
|
/ |
Unkown |
HY-Y0045S |
2-Acetylthiazole-13C2 |
|
/ |
Unkown |